Alternative UPS drug targets upstream the 26S proteasome
Authors:
- Manuel S. RodríguezMRManuel S. Rodríguez
- 1 June 2008
- journal article
- review article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 40 (6-7) , 1126-1140
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- Enantio‐ and Diastereoselective Total Synthesis of (+)‐Panepophenanthrin, a Ubiquitin‐Activating Enzyme Inhibitor, and Biological Properties of Its New DerivativesChemistry – An Asian Journal, 2006
- DNA damage, p14ARF, Nucleophosmin (NPM/B23), and cancerJournal of Molecular Histology, 2006
- Regulation of functional diversity within the Nedd4 family by accessory and adaptor proteinsBioEssays, 2006
- NF‐κB and cancer: Mechanisms and targetsMolecular Carcinogenesis, 2006
- Regulation of BRCA1, BRCA2 and BARD1 intracellular traffickingBioEssays, 2005
- Small‐Molecule Inhibitors and Probes for Ubiquitin‐ and Ubiquitin‐Like‐Specific ProteasesChemBioChem, 2005
- Himeic acid A: a new ubiquitin-activating enzyme inhibitor isolated from a marine-derived fungus, Aspergillus sp.Bioorganic & Medicinal Chemistry Letters, 2005
- Properties of the Nuclear Proteasome Activator PA28γ (REGγ)Archives of Biochemistry and Biophysics, 2000
- The Carboxyl Extensions of Two Rat Ubiquitin Fusion Proteins Are Ribosomal Proteins S27a and L40Biochemical and Biophysical Research Communications, 1995
- Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85Cell, 1984